Connection

Michael Hallek to Lymphoma, Large B-Cell, Diffuse

Back to Details
This is a "connection" page, showing publications Michael Hallek has written about Lymphoma, Large B-Cell, Diffuse.
Michael Hallek
Connection Strength
0.630
Lymphoma, Large B-Cell, Diffuse
  1. Copanlisib for treatment of B-cell malignancies: the development of a PI3K inhibitor with considerable differences to idelalisib. Drug Des Devel Ther. 2018; 12:2577-2590.
    View in: PubMed
    Score: 0.630
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.